Physician profile
Anthony L Mark
NPI 1629128947
$25,286.68
in general payments reported to CMS, 2019-2025
11 companies · $8,369 in 2025
The $8,369 reported for 2025 was more than what 94% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,011 · 2020: $395 · 2021: $5,063 · 2022: $532 · 2023: $3,079 · 2024: $2,837 · 2025: $8,369.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $6,011 · Food and Beverage: $4,293 · Travel and Lodging: $3,981.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $6,010.81 |
| Food and Beverage | $4,292.80 |
| Travel and Lodging | $3,981.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,047.13 | 2020-2025 | |
| W. L. Gore & Associates, INC. | $7,978.36 | 2019-2025 | Seamguard, Gore Synecor Biomaterial, Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Medtronic, INC. | $3,319.97 | 2021-2025 | Signia, Ligasure, Valleylab Ft10 |
| Boston Scientific Corporation | $1,555.30 | 2019-2025 | Overstitch Endoscopic Suturing System |
| Davol INC. | $914.43 | 2023-2025 | Phasix Mesh |
| Covidien LP | $581.85 | 2019-2020 | |
| Apollo Endosurgery US INC | $477.01 | 2023 | Overstitch Endoscopic Suturing System |
| Teleflex LLC | $193.26 | 2024-2025 | Titan Sgs, Titan Sgs Bailout Chuck |
| Novo Nordisk INC | $124.99 | 2019 | |
| Endogastric Solutions, INC | $53.97 | 2019 | |
| Ethicon US, LLC | $40.41 | 2021-2025 | Echelon Endopath, Echelon Circular, Echelon Flex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Mark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.